Latvia vs Panama: Number of isolates tested for extended-spectrum cephalosporins
Latvia
5
in 2018
Panama
9
in 2018
Latvia rank
49th
Panama rank
47th
Number of isolates tested for extended-spectrum cephalosporins over time
- Latvia
- Panama
How they compare
Panama currently reports 9 against 5 in Latvia, a difference of 4.
That makes Panama's figure about 1.8 times Latvia's.
The two have swapped places 1 time across 5 shared years of data; in 2010 it was Latvia ahead.
Latvia ranks 49th and Panama ranks 47th of 51 countries.
Latvia has averaged higher in every one of the 1 decades both report.
Frequently asked questions
- Which has higher number of isolates tested for extended-spectrum cephalosporins, Latvia or Panama?
- Panama, at 9 against 5 in Latvia as of 2018.
- What is the difference in number of isolates tested for extended-spectrum cephalosporins between Latvia and Panama?
- 4, with Panama ahead.
- How many years of comparable data are there for Latvia and Panama?
- 5 years are reported by both, from 2010 to 2018.
- How do Latvia and Panama rank globally for number of isolates tested for extended-spectrum cephalosporins?
- Latvia ranks 49th and Panama ranks 47th of 51 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Number of isolates tested for extended-spectrum cephalosporins. Statizoid refreshes it automatically from the source and publishes the full history for both places.